Groundwork BioAg

**Product and the concrete problem.** Groundwork BioAg addresses two linked agricultural problems: growers need to produce more food under drought, fertilizer, soil-degradation, and climate pressure, while the conventional input system remains dependent on expensive mineral fertilizer and increasingly fragile supply chains. Its core commercial product is Rootella, a portfolio of concentrated arbuscular mycorrhizal fungal inoculants for mainstream agriculture. The fungi colonize crop roots and extend the effective root system through microscopic hyphal networks, helping plants access nutrients and water that are less available to an uncolonized root system. The customer is not buying a consumer wellness product or a generic soil additive; the intended value is measurable field performance through yield, nutrient-use efficiency, crop resilience, and soil biology. Groundwork also sells DYNOMYCO for specialty crops and operates Rootella Carbon, a program designed to let participating farmers earn revenue from durable soil-carbon removal alongside agronomic benefits. The concrete problem is therefore operational: improve output and resilience on existing farmland without requiring farmers to redesign their entire production system.

**Core technology and how it works.** Mycorrhizae are symbiotic fungi that attach to plant roots and exchange nutrients and carbon with the host plant. Groundwork's technical distinction is its claimed ability to produce highly concentrated, vigorous inoculants at industrial volume and at a cost suitable for broad-acre farming, a scaling problem that has kept many biologicals in niche markets. The company licensed initial technology from Israel's Agricultural Research Organization at the Volcani Center and developed a proprietary production process around it. Public technical descriptions say the process produces inoculants reported to be 10 to 100 times more potent than competing products on propagule concentration, although that comparison is company- or interview-sourced and should be independently benchmarked. Rootella is available in liquid, granular, and powder formulations designed to fit seed treatment or existing cultivation workflows; the 2025 Rootella Forte announcement says the powder formulation can treat roughly twice the acreage with the same amount of product as an earlier formulation. The second technical layer is Rootella Carbon: field onboarding, plot-level measurement and remeasurement, data management, and methodology compliance intended to quantify soil-carbon outcomes. This is a biological manufacturing and measurement platform, not merely a bag of microbes.

**Market, customers, and go-to-market.** Groundwork sells through agricultural distributors, crop-input partners, agronomists, and strategic channel relationships rather than asking every farmer to adopt a novel direct-sales workflow. Its addressable customers include row-crop growers, specialty-crop and cannabis operators, seed companies, crop-input distributors, and food or agricultural companies seeking lower-impact supply. The company reported Rootella commercialization in the United States, Brazil, India, Ukraine, Canada, Europe, China, Argentina, and South Africa, and its current company page lists 23 established commercial markets and offices or operations across Israel, the United States, Brazil, India, China, and Canada. In July 2026, Syngenta announced a strategic partnership in which it will market mycorrhiza-based products and soil-carbon solutions under its own label, initially for corn, soy, cereals, and sunflower in Latin America and Europe. Groundwork is responsible for manufacturing, supply, digital tooling, and development of the carbon program, giving it a capital-efficient route to distribution through a global incumbent while retaining control of the technical and operational layer. Earlier distribution for DYNOMYCO through GrowGeneration shows that the company has also pursued specialty-crop channels.

**Traction, funding, and third-party validation.** The public traction record is unusually concrete for an agricultural-biologicals startup. Groundwork's current site reports 13.7 million acres treated cumulatively by the end of 2025 and an estimated 27 million metric tons of carbon dioxide equivalent sequestered; these are company-reported figures, not independent audit results, but they indicate a product deployed beyond laboratory trials. The company announced an $11 million venture financing in May 2021 led by Ibex Investors, with ProDelta and Future Foodways and earlier investors including MoreVC, Middleland Capital, Axess Ventures, and BPD Agri participating. An earlier Series B amount was reported as undisclosed. BASF Venture Capital lists Groundwork as a 2022 portfolio investment and describes Rootella's integration into planting and fertility programs. Fast Company named Groundwork the third most innovative food company in 2022 for its food-security, soil-health, and climate work. The 2026 Syngenta partnership is the strongest recent commercial signal because it assigns a major global agricultural company a route to market while Groundwork supplies manufacturing and program infrastructure. Registration of Rootella in China, Argentina, and South Africa and an organic-input listing through OMRI add regulatory and distribution evidence, but do not establish revenue, gross margin, repeat-purchase rate, or independently verified carbon permanence.

**Founders and team background.** Groundwork was founded in 2014, according to the company's 2025 leadership announcement. The founding group is associated with Dr. Yossi Kofman, Dan Grotsky, and Danny Levy, whose collaboration linked entrepreneurship and agricultural commercialization with Volcani Center mycorrhiza research. Kofman grew the company from its early development phase and became chairman in 2025 when Alon Werber was appointed chief executive officer. The leadership transition is strategically meaningful: Werber brings experience scaling technology businesses, while the company retains Kofman as board chair and Grotsky in a senior growth role. Groundwork's public materials also identify agricultural and biologicals executives such as Hanan Dor, a former ICL Fertilizers and Chemicals executive, and local-market hires in Brazil with experience at Syngenta, Bayer, Monsanto, and Limagrain. LinkedIn lists roughly 54 employees and a 51-200 company-size band, which is large enough to support product, regulatory, manufacturing, and channel work but still small relative to global crop-input incumbents. The key team diligence question is whether the organization can operate a multi-country biologicals supply chain and carbon measurement system without losing scientific quality or execution focus.

**Competitive dynamics.** Groundwork competes with several different solution classes. Pivot Bio and other microbial-input companies use living microorganisms to improve nutrient availability; Bioceres Crop Solutions combines biologicals with seeds and crop traits; Indigo Ag and similar platforms pair agricultural products with carbon or digital programs; and Novonesis, BASF, Bayer, and Corteva bring much greater regulatory, manufacturing, distribution, and farmer-access resources. Traditional synthetic fertilizer and crop-protection programs remain the incumbent approach because they are familiar, standardized, and embedded in farm economics. Groundwork's plausible edge is the combination of a long-developed mycorrhizal production process, high concentration, formulations that fit existing planting routines, global registration experience, and a carbon program that turns the same field intervention into an additional economic proposition. Its partnership with Syngenta may reduce channel friction and validate the product category, but it also gives a powerful partner negotiating leverage and makes Groundwork partly dependent on another company's priorities. The moat is not the general idea that fungi help plants; it must be reproducible strain performance, potency, formulation stability, manufacturing yield, field data across crops and geographies, regulatory know-how, and trusted measurement of carbon outcomes.

**Food-security, resilience, and dual-use relevance.** Groundwork's dual-use case is substantive but civilian-first. There is no public evidence reviewed here of a defense contract, military customer, classified program, or direct national-security deployment, so the strategic assessment should not imply one. The resilience relevance comes from the core technology's ability to increase agricultural output and water-use efficiency on existing land, reduce exposure to phosphorus and other fertilizer constraints, support crops under drought and heat stress, and diversify food production away from a single input regime. Those capabilities matter to national food security, humanitarian supply continuity, and allied agricultural resilience, especially in regions where water scarcity, fertilizer-price shocks, conflict, or disrupted trade threaten planting decisions. The Rootella Carbon model could also create a financial incentive for soil restoration and improve long-term water retention and erosion resistance, although credit quality and permanence require rigorous measurement. The same distributed biological-input and farm-data infrastructure could support resilience planning for strategic agricultural regions, but it is not a substitute for irrigation, seed genetics, farm equipment, or secure logistics. dual_use is therefore true because the commercial product directly serves food and climate resilience, with defense relevance as an enabling and supply-chain adjacency rather than a fielded military capability.

**Growth stage, trajectory, and key diligence risks.** Groundwork is best classified as mature for this database's stage taxonomy: it was founded in 2014, has product registrations and commercial markets across multiple continents, reports millions of treated acres, has a global operating footprint, and is entering a strategic go-to-market partnership with Syngenta. Mature does not mean low risk or independently verified performance. The public record does not disclose current revenue, profitability, total funding, retention, unit economics, or the exact legal perimeter of every country operation. Key diligence should focus on (1) independent field trials that separate Rootella's effect from soil, weather, seed, and management variables; (2) manufacturing yield, contamination control, shelf life, and batch-to-batch potency; (3) the economics of application, farmer payback, and repeat purchase; (4) the legal and operational allocation of manufacturing, data, branding, and carbon-credit responsibilities under the Syngenta partnership; (5) verification of Rootella Carbon's measurement, reporting, verification, and permanence assumptions; (6) regulatory registration and import constraints in each priority market; and (7) dependence on distributors, climate variability, and agricultural commodity cycles. The upside is a rare Israeli deep-tech company that has translated biological research into a scaled food-resilience input and a new carbon program. The downside is that biological performance is context-dependent and carbon markets, channel partners, and farmer adoption can all move slower than the strategic narrative. This is a strategic diligence assessment, not an investment recommendation.